Insider · CIK 0001631248

High Katherine A

Reports to the SEC for 3 companies · WILMINGTON, DE

sec.gov

Transactions

Companies

Filings

CIK

0001631248

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-08	INCYINCYTE CORPA Award	Director	AAward	+1,642 sh	—	—	14,983
2026-06-08	INCYINCYTE CORP · Non Qualfied Stock Option (right to buy)A Award	Director	AAward	+6,111 sh	—	—	6,111
2026-06-05	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2025-06-10	INCYINCYTE CORPA Award	Director	AAward	+2,518 sh	—	—	13,341
2025-06-10	INCYINCYTE CORP · Non Qualfied Stock Option (right to buy)A Award	Director	AAward	+9,216 sh	—	—	9,216
2025-06-05	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2024-06-12	INCYINCYTE CORPA Award	Director	AAward	+2,830 sh	—	—	10,823
2024-06-12	INCYINCYTE CORP · Non Qualfied Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,517
2024-05-30	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2023-06-14	INCYINCYTE CORPA Award	Director	AAward	+2,505 sh	—	—	7,993
2023-06-14	INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,294
2023-06-08	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2022-06-15	INCYINCYTE CORPA Award	Director	AAward	+2,144 sh	—	—	5,488
2022-06-15	INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+9,124 sh	—	—	9,124
2022-06-09	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2021-06-10	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-05-26	INCYINCYTE CORPA Award	Director	AAward	+1,923 sh	—	—	3,344
2021-05-26	INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+8,010 sh	—	—	8,010
2020-06-11	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2020-05-26	INCYINCYTE CORPA Award	Director	AAward	+1,282 sh	—	—	1,421
2020-05-26	INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+10.5K sh	—	—	10,514
2020-03-26	INCYINCYTE CORPA Award	Director	AAward	+139 sh	—	—	139
2020-03-26	INCYINCYTE CORP · Non-Qualified Stock OptionA Award	Director	AAward	+1,285 sh	—	—	1,285
2019-12-17	Spark Therapeutics, Inc.U Disposition from Tender	Director, See Remarks	UDisposition from Tender	−279K sh	$114.50	−$31.9M	0
2019-12-17	Spark Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−35K sh	—	—	0
2019-12-17	Spark Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−23.6K sh	—	—	0
2019-12-17	Spark Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−15.8K sh	—	—	0
2019-12-17	Spark Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−13.8K sh	—	—	0
2019-12-17	Spark Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−21.3K sh	—	—	0
2019-06-11	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2019-03-21	Spark Therapeutics, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+73.2K sh	$3.45	+$253K	287,717
2019-03-21	Spark Therapeutics, Inc.F Tax Payment	Director, See Remarks	FTax Payment	−31.7K sh	$113.25	−$3.58M	256,064
2019-03-21	Spark Therapeutics, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+5,840 sh	$68.45	+$400K	261,904
2019-03-21	Spark Therapeutics, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+3 sh	$40.44	+$121.32	261,907
2019-03-21	Spark Therapeutics, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+64.2K sh	$68.45	+$4.39M	326,067
2019-03-21	Spark Therapeutics, Inc.F Tax Payment	Director, See Remarks	FTax Payment	−49.6K sh	$113.25	−$5.61M	276,506
2019-03-21	Spark Therapeutics, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+21.2K sh	$40.44	+$859K	297,753
2019-03-21	Spark Therapeutics, Inc.F Tax Payment	Director, See Remarks	FTax Payment	−26K sh	$113.26	−$2.94M	271,760
2019-03-21	Spark Therapeutics, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+15.8K sh	$56.17	+$885K	287,510
2019-03-21	Spark Therapeutics, Inc.F Tax Payment	Director, See Remarks	FTax Payment	−11.2K sh	$113.26	−$1.27M	276,326
2019-03-21	Spark Therapeutics, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+7,875 sh	$50.55	+$398K	284,201
2019-03-21	Spark Therapeutics, Inc.F Tax Payment	Director, See Remarks	FTax Payment	−5,367 sh	$113.26	−$608K	278,834
2019-03-21	Spark Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−73.2K sh	—	—	0
2019-03-21	Spark Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−5,840 sh	—	—	64,160
2019-03-21	Spark Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−3 sh	—	—	54,997
2019-03-21	Spark Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−64.2K sh	—	—	0
2019-03-21	Spark Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−41.2K sh	—	—	13,750
2019-03-21	Spark Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−15.8K sh	—	—	15,750
2019-03-21	Spark Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−7,875 sh	—	—	23,625
2019-01-18	Spark Therapeutics, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+2,250 sh	—	—	213,709

Recent filings

Accepted (ET)
Jun 104
High Katherine A0001631248-26-000002
SEC(opens sec.gov)
Jun 94
High Katherine A0001193125-26-264287
SEC(opens sec.gov)
Jun 124
High Katherine A0001628280-25-031007
SEC(opens sec.gov)
Jun 64
High Katherine A0000950170-25-083267
SEC(opens sec.gov)
Jun 144
High Katherine A0000879169-24-000095
SEC(opens sec.gov)
May 314
High Katherine A0000950170-24-067327
SEC(opens sec.gov)
Jun 164
High Katherine A0001209191-23-037798
SEC(opens sec.gov)
Jun 94
High Katherine A0001209191-23-035978
SEC(opens sec.gov)
Jun 174
High Katherine A0001209191-22-037799
SEC(opens sec.gov)
Jun 104
High Katherine A0001209191-22-036048
SEC(opens sec.gov)
Jun 144
High Katherine A0001209191-21-040296
SEC(opens sec.gov)
May 284
High Katherine A0001209191-21-036409
SEC(opens sec.gov)
Jun 154
High Katherine A0001209191-20-036625
SEC(opens sec.gov)
May 284
High Katherine A0001209191-20-032607
SEC(opens sec.gov)

Companies

Address

1801 AUGUSTINE CUTOFF

WILMINGTON, DE, 19803